P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis

Clinical and Vaccine Immunology

Volumn 17, Issue 11, 2010, Pages 1823-1824

  Rajam, Gowrisankar ^a   Bangert, Mathieu ^b   Hammons, Gabrielle M ^a   Melnick, Nikkol ^a   Carlone, George M ^a   Sampson, Jacquelyn S ^a   Ades, Edwin W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; P4 PEPTIDE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; LETTER; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

ADHESINS, BACTERIAL; AGE FACTORS; ANIMALS; ANTIBODIES, BACTERIAL; IMMUNOGLOBULIN G; LIPOPROTEINS; MICE; PNEUMOCOCCAL INFECTIONS; SEPSIS; SURVIVAL ANALYSIS;

EID: 78449261211     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00366-10     Document Type: Letter

References (12)

1. Ginaldi, L., M. De Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, M. P. Corsi, and D. Quaglino. 1999. The immune system in the elderly. I. Specific humoral immunity. Immunol. Res. 20:101-108.
2. Ginaldi, L., M. De Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, V. Martorelli, and D. Quaglino. 1999. The immune system in the elderly. II. Specific cellular immunity. Immunol. Res. 20:109-115.
3. Ginaldi, L., M. De Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, and D. Quaglino. 1999. The immune system in the elderly. III. Innate immunity. Immunol. Res. 20:117-126.
4. Ginaldi, L., M. De Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, and D. Quaglino. 1999. Immunological changes in the elderly. Aging (Milano) 11: 281-286.
5. Gong, Y., and D. R. Koh. 2010. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 339:437-448.
6. Hinojosa, E., A. R. Boyd, and C. J. Orihuela. 2009. Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J. Infect. Dis. 200:546-554.
7. Mares, C. A., S. S. Ojeda, Q. Li, E. G. Morris, J. J. Coalson, and J. M. Teale. 2010. Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections. Exp. Gerontol. 45:91-96.
8. Melnick, N., G. Rajam, G. M. Carlone, J. S. Sampson, and E. W. Ades. 2009. Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model. Clin. Vaccine Immunol. 16:806-810.
9. Pinner, R. W. 1996. Addressing the challenges of emerging infectious disease. Am. J. Med. Sci. 311:3-8.
10. Rajam, G., D. J. Phillips, E. White, J. Anderton, C. W. Hooper, J. S. Sampson, G. M. Carlone, E. W. Ades, and S. Romero-Steiner. 2008. A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization. Microb. Pathog. 44:186-196.
11. Rajam, G., J. Sampson, G. M. Carlone, and E. W. Ades. 2010. An augmented passive immune therapy to treat fulminant bacterial infections. Recent Pat. Antiinfect. Drug Discov. 5:157-167.
12. Rajam, G., J. Skinner, N. Melnick, J. Martinez, G. M. Carlone, J. S. Sampson, and E. W. Ades. 2009. A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection. J. Infect. Dis. 199:1233-1238.